National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 8) (Cth)

Case

PB 118 of 2022

National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 8)

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated    30 November 2022

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

1  Name

This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 8).

This instrument may also be cited as PB 118 of 2022.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1 Column 2 Column 3
Provisions Commencement Date/Details
1.  The whole of this instrument 1 December 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under section 85B of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1. Schedule 1- after entry for Atomoxetine

Insert

Azathioprine Tablet 25 mg Oral Imuran 100 9.32 13.97
Tablet 50 mg Oral Imuran 100 15.88 20.53
  1. Schedule 1- entry for Bisoprolol

Omit

Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Bicor 28 4.90 9.76
Tablet containing bisoprolol fumarate 5 mg Oral Bicor 28 6.12 10.98
Tablet containing bisoprolol fumarate 10 mg Oral Bicor 28 7.65 12.51

Insert

Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg Oral Bicor 28 4.90 11.17
Tablet containing bisoprolol fumarate 5 mg Oral Bicor 28 6.12 12.35
Tablet containing bisoprolol fumarate 10 mg Oral Bicor 28 7.65 13.89
  1. Schedule 1- after entry for Cefalexin

Insert

Cefuroxime Tablet 250 mg (as axetil) Oral Zinnat 20 6.76 12.45
  1. Schedule 1- entry for Diltiazem

Omit

Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg Oral Cardizem CD 30 6.25 8.02
Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg Oral Cardizem CD 30 8.45 10.22
Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg Oral Cardizem CD 30 11.08 12.84

Insert

Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg Oral Cardizem CD 30 6.25 8.02
Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg Oral Cardizem CD 30 8.45 10.22
Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg Oral Cardizem CD 30 11.08 12.84
Tablet containing diltiazem hydrochloride 60 mg Oral Cardizem 90 7.40 9.17
  1. Schedule 1- entry for Esomeprazole

Omit

Esomeprazole Tablet (enteric coated) 20 mg (as magnesium trihydrate) Oral Nexium 30 4.00 7.17
Tablet (enteric coated) 40 mg (as magnesium trihydrate) Oral Nexium 30 6.79 9.96

Insert

Esomeprazole Tablet (enteric coated) 20 mg (as magnesium trihydrate) Oral Nexium 30 4.00 10.51
Tablet (enteric coated) 40 mg (as magnesium trihydrate) Oral Nexium 30 6.79 13.30
  1. Schedule 1- entry for Flecainide

Omit

Flecainide Tablet containing flecainide acetate 50 mg Oral Tambocor 60 18.14 19.56
Tablet containing flecainide acetate 100 mg Oral Tambocor 60 22.49 23.91

Insert

Flecainide Tablet containing flecainide acetate 50 mg Oral Tambocor 60 18.14 21.10
Tablet containing flecainide acetate 100 mg Oral Tambocor 60 22.49 25.46
  1. Schedule 1- entry for Labetalol

Omit

Labetalol Tablet containing labetalol hydrochloride 100 mg Oral Trandate 100 12.32 15.58
  1. Schedule 1- entry for Lamotrigine

Omit

Lamotrigine Tablet 25 mg Oral Lamictal 56 4.25 5.48
Tablet 50 mg Oral Lamictal 56 7.08 8.18
Tablet 100 mg Oral Lamictal 56 11.79 12.94
Tablet 200 mg Oral Lamictal 56 19.82 20.96

Insert

Lamotrigine Tablet 25 mg Oral Lamictal 56 4.25 8.48
Tablet 50 mg Oral Lamictal 56 7.08 11.22
Tablet 100 mg Oral Lamictal 56 11.79 15.93
Tablet 200 mg Oral Lamictal 56 19.82 23.96
  1. Schedule 1- entry for Levonorgestrel with ethinylestradiol

Omit

Levonorgestrel with ethinylestradiol Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets Oral Levlen ED 4 4.75 7.84

Insert

Levonorgestrel with ethinylestradiol Pack containing 21 tablets 150 micrograms 30 micrograms and 7 inert tablets Oral Levlen ED 4 4.75 9.37
  1. Schedule 1- entry for Metoprolol

Omit

Metoprolol Tablet containing metoprolol tartrate 50 mg Oral Betaloc 100 2.50 12.25
Tablet containing metoprolol tartrate 100 mg Oral Betaloc 60 2.76 12.52

Insert

Metoprolol Tablet containing metoprolol tartrate 50 mg Oral Betaloc 100 2.50 14.75
Tablet containing metoprolol tartrate 100 mg Oral Betaloc 60 2.76 14.99
  1. Schedule 1- entry for Olmesartan with amlodipine

Omit

Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) Oral Sevikar 40/5 30 6.96 9.41
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) Oral Sevikar 40/10 30 7.46 9.91

Insert

Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) Oral Sevikar 40/5 30 6.96 9.75
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) Oral Sevikar 40/10 30 7.46 10.25
  1. Schedule 1- entry for Olmesartan with amlodipine and hydrochlorothiazide

Omit

Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 20/5/12.5 30 5.57 8.36
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 40/5/12.5 30 9.37 12.16
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg Oral Sevikar HCT 40/5/25 30 10.83 13.62
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 40/10/12.5 30 9.81 12.56
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg Oral Sevikar HCT 40/10/25 30 11.26 14.02

Insert

Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 20/5/12.5 30 5.57 8.36
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 40/5/12.5 30 9.37 12.16
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg Oral Sevikar HCT 40/5/25 30 10.83 13.62
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg Oral Sevikar HCT 40/10/12.5 30 9.81 12.56
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg Oral Sevikar HCT 40/10/25 30 11.26 14.05
  1. Schedule 1- entry for Quetiapine

Omit

Quetiapine Tablet 25 mg (as fumarate) Oral Seroquel 60 4.00 7.42
Tablet (modified release) 50 mg (as fumarate) Oral Seroquel XR 60 7.86 11.33
Tablet 100 mg (as fumarate) Oral Seroquel 90 11.11 14.47
Tablet (modified release) 150 mg (as fumarate) Oral Seroquel XR 60 11.11 18.34
Tablet (modified release) 200 mg (as fumarate) Oral Seroquel XR 60 22.87 24.32
Tablet 200 mg (as fumarate) Oral Seroquel 60 15.14 18.50
Tablet (modified release) 300 mg (as fumarate) Oral Seroquel XR 60 29.37 30.82
Tablet 300 mg (as fumarate) Oral Seroquel 60 22.23 25.59
Tablet (modified release) 400 mg (as fumarate) Oral Seroquel XR 60 40.04 41.49

Insert

Quetiapine Tablet 25 mg (as fumarate) Oral Seroquel 60 4.00 14.33
Tablet (modified release) 50 mg (as fumarate) Oral Seroquel XR 60 7.86 18.09
Tablet 100 mg (as fumarate) Oral Seroquel 90 11.11 21.34
Tablet (modified release) 150 mg (as fumarate) Oral Seroquel XR 60 11.11 27.86
Tablet (modified release) 200 mg (as fumarate) Oral Seroquel XR 60 22.87 33.10
Tablet 200 mg (as fumarate) Oral Seroquel 60 15.14 25.37
Tablet (modified release) 300 mg (as fumarate) Oral Seroquel XR 60 29.37 39.60
Tablet 300 mg (as fumarate) Oral Seroquel 60 22.23 32.46
Tablet (modified release) 400 mg (as fumarate) Oral Seroquel XR 60 40.04 50.27
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0